Lymphatic Vasculature Requires Estrogen Receptor-α Signaling to Protect From Lymphedema

Morfoisse, Florent; Tatin, Florence; Chaput, Benoit; Therville, Nicole; Vaysse, Charlotte; Métivier, Raphael; Malloizel-Delaunay, Julie; Pujol, Françoise; Godet, Anne-claire; De Toni, Fabienne; Boudou, Fréderic; Grenier, katia; Dubuc, David; Lacazette, Eric; Prats, Anne-catherine; Guillermet-Guibert, Julie; Lenfant, Françoise; Garmy-susini, Barbara

doi:10.1161/ATVBAHA.118.310997

Download

Article (Scientific journals)

Lymphatic Vasculature Requires Estrogen Receptor-α Signaling to Protect From Lymphedema

Morfoisse, Florent; Tatin, Florence; Chaput, Benoit et al.

2018 • In Arteriosclerosis, Thrombosis and Vascular Biology

Peer Reviewed verified by ORBi

Permalink
https://hdl.handle.net/2268/228016

DOI
10.1161/ATVBAHA.118.310997

PubMed
29650694

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

ATVBAHA.118.310997.pdf

Publisher postprint (2.39 MB)

Download

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Keywords :

lymphedema; lymphatic endothelium; estradiol

Disciplines :

Biochemistry, biophysics & molecular biology

Author, co-author :

Morfoisse, Florent ^✱; Université de Liège - ULiège > Département des sciences cliniques > Labo de biologie des tumeurs et du développement

Tatin, Florence ^✱; Institute of Metabolic and Cardiovascular Diseases of Toulouse, Université de Toulouse

Chaput, Benoit; Department of Plastic Surgery, Centre Hospitalo-Universitaire Rangueil, Toulouse, France

Therville, Nicole; Unité Mixte de Recherche 1037-Centre de Recherche en Cancérologie de Toulouse Inserm, Université Paul Sabatier, France

Vaysse, Charlotte; Department of Gynecology Surgery, IUCT-Oncopole, Toulouse, France

Métivier, Raphael; Unité Mixte de Recherche Centre National de la Recherche Scientifique 6290, Rennes, France (

Malloizel-Delaunay, Julie; Department of Vascular Medicine Centre Hospitalo-Universitaire Rangueil, Toulouse, France

Pujol, Françoise; Institute of Metabolic and Cardiovascular Diseases of Toulouse, Université de Toulouse

Godet, Anne-claire; Institute of Metabolic and Cardiovascular Diseases of Toulouse, Université de Toulouse

De Toni, Fabienne; Institute of Metabolic and Cardiovascular Diseases of Toulouse, Université de Toulouse

More authors (8 more)

^✱ These authors have contributed equally to this work.

Language :

English

Title :

Lymphatic Vasculature Requires Estrogen Receptor-α Signaling to Protect From Lymphedema

Publication date :

2018

Journal title :

Arteriosclerosis, Thrombosis and Vascular Biology

ISSN :

1079-5642

eISSN :

1524-4636

Publisher :

Lippincott Williams and Wilkins, Philadelphia, United States - Pennsylvania

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 24 September 2018

Statistics

Number of views

368 (6 by ULiège)

Number of downloads

405 (5 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

Bibliography

Arnal JF, Gourdy P, Elhage R, Garmy-Susini B, Delmas E, Brouchet L, Castano C, Barreira Y, Couloumiers JC, Prats H, Prats AC, Bayard F. Estrogens and atherosclerosis. Eur J Endocrinol. 2004;150:113-117.
Chambliss KL, Shaul PW. Estrogen modulation of endothelial nitric oxide synthase. Endocr Rev. 2002;23:665-686. doi: 10.1210/er.2001-0045.
Mendelsohn ME, Karas RH. Molecular and cellular basis of cardiovascular gender differences. Science. 2005;308:1583-1587. doi: 10.1126/science.1112062.
Levin ER. Integration of the extranuclear and nuclear actions of estrogen. Mol Endocrinol. 2005;19:1951-1959. doi: 10.1210/me.2004-0390.
Thornton JW, Need E, Crews D. Resurrecting the ancestral steroid receptor: Ancient origin of estrogen signaling. Science. 2003;301:1714-1717. doi: 10.1126/science.1086185.
Krust A, Green S, Argos P, Kumar V, Walter P, Bornert JM, Chambon P. The chicken oestrogen receptor sequence: homology with v-erbA and the human oestrogen and glucocorticoid receptors. EMBO J. 1986;5:891-897.
Brouchet L, Krust A, Dupont S, Chambon P, Bayard F, Arnal JF. Estradiol accelerates reendothelialization in mouse carotid artery through estrogen receptor-Alpha but not estrogen receptor-beta. Circulation. 2001;103:423-428.
Arnal JF, Fontaine C, Abot A, Valera MC, Laurell H, Gourdy P, Lenfant F. Lessons from the dissection of the activation functions (AF-1 and AF-2) of the estrogen receptor alpha in vivo. Steroids. 2013;78:576-582. doi: 10.1016/j.steroids.2012.11.011.
Klinge CM. Estrogen receptor interaction with estrogen response elements. Nucleic Acids Res. 2001;29:2905-2919.
Li C, Briggs MR, Ahlborn TE, Kraemer FB, Liu J. Requirement of Sp1 and estrogen receptor alpha interaction in 17beta-estradiol-mediated transcriptional activation of the low density lipoprotein receptor gene expression. Endocrinology. 2001;142:1546-1553. doi: 10.1210/endo.142.4.8096.
Stossi F, Likhite VS, Katzenellenbogen JA, Katzenellenbogen BS. Estrogen-occupied estrogen receptor represses cyclin G2 gene expression and recruits a repressor complex at the cyclin G2 promoter. J Biol Chem. 2006;281:16272-16278. doi: 10.1074/jbc.M513405200.
Razandi M, Pedram A, Park ST, Levin ER. Proximal events in signaling by plasma membrane estrogen receptors. J Biol Chem. 2003;278:2701-2712. doi: 10.1074/jbc.M205692200.
Levin ER. Cellular functions of plasma membrane estrogen receptors. Steroids. 2002;67:471-475.
Shu YY, Maibach HI. Estrogen and skin: Therapeutic options. Am J Clin Dermatol. 2011;12:297-311. doi: 10.2165/11589180-000000000-00000.
Jackson DG. Immunological functions of hyaluronan and its receptors in the lymphatics. Immunol Rev. 2009;230:216-231. doi: 10.1111/j.1600-065X.2009.00803.x.
Schrott HG, Bittner V, Vittinghoff E, Herrington DM, Hulley S. Adherence to National Cholesterol Education Program Treatment goals in postmenopausal women with heart disease. The Heart and Estrogen/Progestin Replacement Study (HERS). The HERS Research Group. JAMA. 1997;277:1281-1286.
Alitalo K, Tammela T, Petrova TV. Lymphangiogenesis in development and human disease. Nature. 2005;438:946-953. doi: 10.1038/nature04480.
Greene R, Fowler R. Physical therapy management of primary lymphedema in the lower extremities: A case report. Physiother Theory Pract. 2010;26:62-68. doi: 10.3109/09593980802667854.
Smeltzer DM, Stickler GB, Schirger A. Primary lymphedema in children and adolescents: A follow-up study and review. Pediatrics. 1985;76:206-218.
Sener SF, Winchester DJ, Martz CH, Feldman JL, Cavanaugh JA, Winchester DP, Weigel B, Bonnefoi K, Kirby K, Morehead C. Lymphedema after sentinel lymphadenectomy for breast carcinoma. Cancer. 2001;92:748-752.
Petrova TV, Karpanen T, Norrmén C, Mellor R, Tamakoshi T, Finegold D, Ferrell R, Kerjaschki D, Mortimer P, Ylä-Herttuala S, Miura N, Alitalo K. Defective valves and abnormal mural cell recruitment underlie lymphatic vascular failure in lymphedema distichiasis. Nat Med. 2004;10:974-981. doi: 10.1038/nm1094.
Slavin SA, Van den Abbeele AD, Losken A, Swartz MA, Jain RK. Return of lymphatic function after flap transfer for acute lymphedema. Ann Surg. 1999;229:421-427.
Specht MC, Miller CL, Skolny MN, Jammallo LS, O'Toole J, Horick N, Isakoff SJ, Smith BL, Taghian AG. Residual lymph node disease after neoadjuvant chemotherapy predicts an increased risk of lymphedema in nodepositive breast cancer patients. Ann Surg Oncol. 2013;20:2835-2841. doi: 10.1245/s10434-012-2828-y.
Swaroop MN, Ferguson CM, Horick NK, Skolny MN, Miller CL, Jammallo LS, Brunelle CL, O'Toole JA, Isakoff SJ, Specht MC, Taghian AG. Impact of adjuvant taxane-based chemotherapy on development of breast cancer-related lymphedema: results from a large prospective cohort. Breast Cancer Res Treat. 2015;151:393-403. doi: 10.1007/s10549-015-3408-1.
Warren LE, Miller CL, Horick N, Skolny MN, Jammallo LS, Sadek BT, Shenouda MN, O'Toole JA, MacDonald SM, Specht MC, Taghian AG. The impact of radiation therapy on the risk of lymphedema after treatment for breast cancer: A prospective cohort study. Int J Radiat Oncol Biol Phys. 2014;88:565-571. doi: 10.1016/j.ijrobp.2013.11.232.
Rutkowski JM, Moya M, Johannes J, Goldman J, Swartz MA. Secondary lymphedema in the mouse tail: lymphatic hyperplasia, VEGF-C upregulation, and the protective role of MMP-9. Microvasc Res. 2006;72:161-171. doi: 10.1016/j.mvr.2006.05.009.
Karkkainen MJ, Saaristo A, Jussila L, Karila KA, Lawrence EC, Pajusola K, Bueler H, Eichmann A, Kauppinen R, Kettunen MI, Yla-Herttuala S, Finegold DN, Ferrell RE, Alitalo K. A model for gene therapy of human hereditary lymphedema. Proc Natl Acad Sci USA. 2001;98:12677-12682.
Daily K, Patel VR, Rigor P, Xie X, Baldi P. MotifMap: integrative genome-wide maps of regulatory motif sites for model species. BMC Bioinformatics. 2011;12:495. doi: 10.1186/1471-2105-12-495.
Rosenbloom KR, Armstrong J, Barber GP, et al. The UCSC Genome Browser database: 2015 update. Nucleic Acids Res. 2015;43(Database issue):D670-D681. doi: 10.1093/nar/gku1177.
Prats AC, Van den Berghe L, Rayssac A, Ainaoui N, Morfoisse F, Pujol F, Legonidec S, Bikfalvi A, Prats H, Pyronnet S, Garmy-Susini B. CXCL4L1-fibstatin cooperation inhibits tumor angiogenesis, lymphangiogenesis and metastasis. Microvasc Res. 2013;89:25-33. doi: 10.1016/j.mvr.2013.05.005.
Campbell L, Emmerson E, Williams H, Saville CR, Krust A, Chambon P, Mace KA, Hardman MJ. Estrogen receptor-Alpha promotes alternative macrophage activation during cutaneous repair. J Invest Dermatol. 2014;134:2447-2457. doi: 10.1038/jid.2014.175.
Ghanta S, Cuzzone DA, Torrisi JS, Albano NJ, Joseph WJ, Savetsky IL, Gardenier JC, Chang D, Zampell JC, Mehrara BJ. Regulation of inflammation and fibrosis by macrophages in lymphedema. Am J Physiol Heart Circ Physiol. 2015;308:H1065-H1077.
Billon-Gales A, Fontaine C, Douin-Echinard V, Delpy L, Berges H, Calippe B, Lenfant F, Laurell H, Guery JC, Gourdy P, Arnal JF. Endothelial estrogen receptor-Alpha plays a crucial role in the atheroprotective action of 17beta-estradiol in low-density lipoprotein receptor-deficient mice. Circulation. 2009;120:2567-2576.
Garmy-Susini B, Avraamides CJ, Schmid MC, Foubert P, Ellies LG, Barnes L, Feral C, Papayannopoulou T, Lowy A, Blair SL, Cheresh D, Ginsberg M, Varner JA. Integrin alpha4beta1 signaling is required for lymphangiogenesis and tumor metastasis. Cancer Res. 2010;70:3042-3051. doi: 10.1158/0008-5472.CAN-09-3761.
Zheng W, Aspelund A, Alitalo K. Lymphangiogenic factors, mechanisms, and applications. J Clin Invest. 2014;124:878-887. doi: 10.1172/JCI71603.
Evans MJ, Harris HA, Miller CP, Karathanasis SK, Adelman SJ. Estrogen receptors alpha and beta have similar activities in multiple endothelial cell pathways. Endocrinology. 2002;143:3785-3795. doi: 10.1210/en.2002-220356.
Röck K, Meusch M, Fuchs N, Tigges J, Zipper P, Fritsche E, Krutmann J, Homey B, Reifenberger J, Fischer JW. Estradiol protects dermal hyaluronan/versican matrix during photoaging by release of epidermal growth factor from keratinocytes. J Biol Chem. 2012;287:20056-20069. doi: 10.1074/jbc.M112.353151.
Ji RC. Lymphatic endothelial cells, lymphangiogenesis, and extracellular matrix. Lymphat Res Biol. 2006;4:83-100. doi: 10.1089/lrb.2006.4.83.
Hervé MA, Meduri G, Petit FG, Domet TS, Lazennec G, Mourah S, Perrot-Applanat M. Regulation of the vascular endothelial growth factor (VEGF) receptor Flk-1/KDR by estradiol through VEGF in uterus. J Endocrinol. 2006;188:91-99. doi: 10.1677/joe.1.06184.
Garmy-Susini B, Delmas E, Gourdy P, Zhou M, Bossard C, Bugler B, Bayard F, Krust A, Prats AC, Doetschman T, Prats H, Arnal JF. Role of fibroblast growth factor-2 isoforms in the effect of estradiol on endothelial cell migration and proliferation. Circ Res. 2004;94:1301-1309. doi: 10.1161/01.RES.0000127719.13255.81.
Arnal JF, Gourdy P, Garmy-Susini B, Delmas E, Bayard F. [Usefulness of experimental models to understand the vascular effects of estrogens]. Med Sci (Paris). 2003;19:1226-1232. doi: 10.1051/medsci/200319121226.
Dietze EC, Troch MM, Bean GR, Heffner JB, Bowie ML, Rosenberg P, Ratliff B, Seewaldt VL. Tamoxifen and tamoxifen ethyl bromide induce apoptosis in acutely damaged mammary epithelial cells through modulation of AKT activity. Oncogene. 2004;23:3851-3862. doi: 10.1038/sj.onc.1207480.